Manzo Pharmaceuticals, Inc.
MNZO · OTC
12/31/2015 | 12/31/2014 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Market Cap | $696 | $408 | $1,732 | $2,901 |
| - Cash | $12 | $11 | $10 | $12 |
| + Debt | -$11 | $89 | $6,523 | $7,315 |
| Enterprise Value | $672 | $487 | $8,245 | $10,204 |
| Revenue | $2 | $1 | $3,070 | $3,003 |
| % Growth | 267.5% | -100% | 2.2% | – |
| Gross Profit | $1 | $1 | $21 | $756 |
| % Margin | 39.4% | 100% | 0.7% | 25.2% |
| EBITDA | $1 | -$449 | -$2,853 | -$2,297 |
| % Margin | 39.4% | -81,886.5% | -93% | -76.5% |
| Net Income | -$36 | -$989 | -$4,150 | -$3,953 |
| % Margin | -1,799.6% | -180,493.8% | -135.2% | -131.6% |
| EPS Diluted | -0 | -0.003 | -1.2 | -1.2 |
| % Growth | 98.9% | 99.8% | 0% | – |
| Operating Cash Flow | – | – | -$1,109 | -$1,583 |
| Capital Expenditures | – | – | -$2 | -$3 |
| Free Cash Flow | – | – | -$1,111 | -$1,586 |